Global Influenza Medication Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Influenza Medication Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Influenza Medication Market Overview:
Global Influenza Medication Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Influenza Medication involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Influenza Medication Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Influenza Medication market in 2020.
Global Influenza Medication Market Segmentation
By Type, Influenza Medication market has been segmented into:
Zanamivir
Oseltamivir phosphate
Peramivir
Other Influenza Medication
By Application, Influenza Medication market has been segmented into:
adult
kids
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Influenza Medication market are:
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
1. Market Overview of Influenza Medication
1.1 Influenza Medication Market Overview
1.1.1 Influenza Medication Product Scope
1.1.2 Market Status and Outlook
1.2 Influenza Medication Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Influenza Medication Historic Market Size by Regions (2015-2020)
1.4 Influenza Medication Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Influenza Medication Sales Market by Type (2015-2026)
2.1 Global Influenza Medication Historic Market Size by Type (2015-2020)
2.2 Global Influenza Medication Forecasted Market Size by Type (2021-2026)
2.3 Zanamivir
2.4 Oseltamivir phosphate
2.5 Peramivir
2.6 Other Influenza Medication
3. Covid-19 Impact Influenza Medication Sales Market by Application (2015-2026)
3.1 Global Influenza Medication Historic Market Size by Application (2015-2020)
3.2 Global Influenza Medication Forecasted Market Size by Application (2021-2026)
3.3 adult
3.4 kids
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Influenza Medication Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Influenza Medication Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Influenza Medication Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Influenza Medication Business
5.1 Bristol-Myers Squibb
5.1.1 Bristol-Myers Squibb Company Profile
5.1.2 Bristol-Myers Squibb Influenza Medication Product Specification
5.1.3 Bristol-Myers Squibb Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 AstraZeneca
5.2.1 AstraZeneca Company Profile
5.2.2 AstraZeneca Influenza Medication Product Specification
5.2.3 AstraZeneca Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Eli Lilly
5.3.1 Eli Lilly Company Profile
5.3.2 Eli Lilly Influenza Medication Product Specification
5.3.3 Eli Lilly Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Roche
5.4.1 Roche Company Profile
5.4.2 Roche Influenza Medication Product Specification
5.4.3 Roche Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 GSK
5.5.1 GSK Company Profile
5.5.2 GSK Influenza Medication Product Specification
5.5.3 GSK Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novartis
5.6.1 Novartis Company Profile
5.6.2 Novartis Influenza Medication Product Specification
5.6.3 Novartis Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Pfizer
5.7.1 Pfizer Company Profile
5.7.2 Pfizer Influenza Medication Product Specification
5.7.3 Pfizer Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Sanofi
5.8.1 Sanofi Company Profile
5.8.2 Sanofi Influenza Medication Product Specification
5.8.3 Sanofi Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Bayer
5.9.1 Bayer Company Profile
5.9.2 Bayer Influenza Medication Product Specification
5.9.3 Bayer Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Celgene
5.10.1 Celgene Company Profile
5.10.2 Celgene Influenza Medication Product Specification
5.10.3 Celgene Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Seqirus
5.11.1 Seqirus Company Profile
5.11.2 Seqirus Influenza Medication Product Specification
5.11.3 Seqirus Influenza Medication Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Influenza Medication Market Size (2015-2026)
6.2 North America Influenza Medication Key Players in North America (2015-2020)
6.3 North America Influenza Medication Market Size by Type (2015-2020)
6.4 North America Influenza Medication Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Influenza Medication Market Size (2015-2026)
7.2 East Asia Influenza Medication Key Players in North America (2015-2020)
7.3 East Asia Influenza Medication Market Size by Type (2015-2020)
7.4 East Asia Influenza Medication Market Size by Application (2015-2020)
8. Europe
8.1 Europe Influenza Medication Market Size (2015-2026)
8.2 Europe Influenza Medication Key Players in North America (2015-2020)
8.3 Europe Influenza Medication Market Size by Type (2015-2020)
8.4 Europe Influenza Medication Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Influenza Medication Market Size (2015-2026)
9.2 South Asia Influenza Medication Key Players in North America (2015-2020)
9.3 South Asia Influenza Medication Market Size by Type (2015-2020)
9.4 South Asia Influenza Medication Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Influenza Medication Market Size (2015-2026)
10.2 Southeast Asia Influenza Medication Key Players in North America (2015-2020)
10.3 Southeast Asia Influenza Medication Market Size by Type (2015-2020)
10.4 Southeast Asia Influenza Medication Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Influenza Medication Market Size (2015-2026)
11.2 Middle East Influenza Medication Key Players in North America (2015-2020)
11.3 Middle East Influenza Medication Market Size by Type (2015-2020)
11.4 Middle East Influenza Medication Market Size by Application (2015-2020)
12. Africa
12.1 Africa Influenza Medication Market Size (2015-2026)
12.2 Africa Influenza Medication Key Players in North America (2015-2020)
12.3 Africa Influenza Medication Market Size by Type (2015-2020)
12.4 Africa Influenza Medication Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Influenza Medication Market Size (2015-2026)
13.2 Oceania Influenza Medication Key Players in North America (2015-2020)
13.3 Oceania Influenza Medication Market Size by Type (2015-2020)
13.4 Oceania Influenza Medication Market Size by Application (2015-2020)
14. South America
14.1 South America Influenza Medication Market Size (2015-2026)
14.2 South America Influenza Medication Key Players in North America (2015-2020)
14.3 South America Influenza Medication Market Size by Type (2015-2020)
14.4 South America Influenza Medication Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Influenza Medication Market Size (2015-2026)
15.2 Rest of the World Influenza Medication Key Players in North America (2015-2020)
15.3 Rest of the World Influenza Medication Market Size by Type (2015-2020)
15.4 Rest of the World Influenza Medication Market Size by Application (2015-2020)
16 Influenza Medication Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Influenza Medication Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|